Kenya Court Denies Rastafarians Religious Exemption for Cannabis Use
Kenyan judiciary rejects constitutional challenge seeking sacramental cannabis rights under religious-freedom protections.

High angle of shiny wooden ceremonial mallet with golden detail placed on judge tale near documents folders
Court Upholds Blanket Cannabis Prohibition
The Kenyan judiciary rejected the Rastafarian petitioners' claim that sacramental cannabis use qualifies for constitutional protection under Article 32 of the 2010 Constitution, which guarantees freedom of conscience and religion. The state's interest in narcotics control outweighs individual religious-practice claims when a substance is listed under Schedule I of the Narcotic Drugs and Psychotropic Substances Control Act, according to the ruling. The court found no compelling evidence that cannabis is indispensable to Rastafarian worship. Nor did it find that less-restrictive alternatives are unavailable.
Petitioners argued that cannabis—referred to as "ganja" or "the holy herb" within Rastafarian theology—is central to meditation, communal gatherings, and spiritual connection. They cited precedent from jurisdictions including Jamaica, which decriminalized possession of up to two ounces for Rastafarian sacramental use in 2015, and South Africa, where the Constitutional Court in 2018 legalized private adult use on privacy grounds. The Kenyan bench distinguished both rulings. It noted that Kenya's statutory framework doesn't carve out religious exemptions and that the petitioners failed to demonstrate harm rising to the level of constitutional injury.
Kenya's Narcotic Drugs and Psychotropic Substances Control Act criminalizes possession, cultivation, and distribution of cannabis without exception. Penalties range from fines of 1 million Kenyan shillings (approximately $7,700 USD) to imprisonment of up to 20 years for trafficking offenses. The statute doesn't include provisions for medical or religious exemptions, and the National Authority for the Campaign Against Alcohol and Drug Abuse has consistently opposed any liberalization.
Regional Context and Enforcement Patterns
The ruling contrasts sharply with emerging cannabis-policy shifts across East Africa, where Uganda, Rwanda, and Lesotho have licensed medical-cannabis cultivation for export while maintaining domestic prohibition. Kenya remains an outlier. It's issued no cultivation licenses. It maintains a zero-tolerance enforcement posture. In 2024 it arrested more than 3,200 individuals on cannabis-related charges, according to data from the Directorate of Criminal Investigations.
Rastafarian communities in Kenya number approximately 5,000 to 8,000 adherents, concentrated in Nairobi, Mombasa, and coastal regions. Advocates estimate that hundreds face annual prosecution under the narcotics statute, though disaggregated arrest data by religious affiliation isn't publicly available. The petitioners' legal team had sought a declaratory order exempting registered Rastafarian congregations from prosecution for possession of quantities below 15 grams, mirroring Jamaica's framework. The court declined to craft such a carve-out, stating that any exemption must originate from the legislature, not the bench.
For background on Kenya's cannabis legal framework and prior reform attempts, see the CannIntel topic hub on Kenya Cannabis Laws.
What Comes Next
Petitioners have 30 days to file an appeal with the Court of Appeal, though legal observers consider reversal unlikely given the narrow grounds for appellate review of constitutional-interpretation questions. The ruling doesn't foreclose future legislative reform. A 2023 private member's bill proposing medical-cannabis legalization and industrial-hemp licensing stalled in committee and hasn't advanced to a floor vote. No parallel bill addressing religious exemptions has been introduced in the current parliamentary session.
The National Authority for the Campaign Against Alcohol and Drug Abuse issued a statement July 18 welcoming the decision and reiterating its position that cannabis poses public-health risks that justify a total ban. The agency cited a 2025 prevalence study estimating that 2.8 percent of Kenyan adults aged 15-64 reported past-year cannabis use, a figure it characterized as evidence of inadequate enforcement rather than grounds for liberalization.
International human-rights monitors, including the United Nations Special Rapporteur on Freedom of Religion or Belief, haven't commented on the ruling. Jamaica's Rastafarian community issued a solidarity statement calling the decision "a denial of fundamental spiritual rights" and urging the Kenyan government to revisit its narcotics policy. No formal diplomatic response has been reported.
The next procedural milestone is the petitioners' deadline to file an appeal, which falls on August 17, 2026. Absent appellate intervention or legislative action, Kenya's blanket cannabis prohibition remains in force with no religious exemptions.
Frequently asked questions
What did the Kenyan court rule on Rastafarian cannabis use?
The court ruled July 18, 2026 that Rastafarians don't hold a constitutional right to use cannabis for religious purposes. The decision upheld Kenya's blanket prohibition under the Narcotic Drugs and Psychotropic Substances Control Act, finding that the state's narcotics-control interest outweighs religious-practice claims.
What are the penalties for cannabis possession in Kenya?
Kenya's Narcotic Drugs and Psychotropic Substances Control Act imposes fines up to 1 million Kenyan shillings (approximately $7,700 USD) and imprisonment ranging from several months to 20 years for trafficking offenses. The statute contains no medical or religious exemptions.
Can the petitioners appeal the ruling?
Yes. The petitioners have 30 days from the July 18 ruling to file an appeal with the Court of Appeal. Legal observers consider reversal unlikely given the narrow grounds for appellate review of constitutional-interpretation questions.
How does Kenya's cannabis policy compare to neighboring countries?
Kenya maintains a zero-tolerance prohibition with no medical or religious exemptions. In contrast, Uganda, Rwanda, and Lesotho have licensed medical-cannabis cultivation for export while keeping domestic use illegal. Jamaica and South Africa have decriminalized or legalized limited personal use.
Are there any pending cannabis-reform bills in Kenya?
A 2023 private member's bill proposing medical-cannabis legalization and industrial-hemp licensing stalled in committee and hasn't advanced. No bills addressing religious exemptions for cannabis use have been introduced in the current parliamentary session.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Saint Kitts and Nevis Enlists Regional Expert for Cannabis Banking Rules
The twin-island federation has retained a Caribbean financial-services consultant to draft banking protocols for its emerging medicinal cannabis sector.

Child Poisoning Cases Mount as New York's Cannabis Rollout Faces Scrutiny
Critics cite pediatric exposures and enforcement gaps as evidence of regulatory failures in the state's 2021 legalization framework.

Canberra Advocates Push to Reform Medicinal Cannabis Driving Laws
Patient groups and lawmakers seek to eliminate zero-tolerance THC rules for prescribed medicinal cannabis users in the Australian Capital Territory.
More from the newsroom

Nine States Still Bar Medical Cannabis Programs as of July 2026
Idaho, Wyoming, Kansas, Nebraska, Wisconsin, Tennessee, Kentucky, South Carolina, and Georgia maintain categorical prohibition of medical cannabis.

Germany Approves Four Cannabis Research Projects Under New Framework
Federal regulators greenlit the first wave of cannabis studies following April's partial legalization.

Florida Medical Marijuana Sales Hit 12.1B mg of THC in 2026
State's medical program moved 4.1 million ounces through first half of 2026, signaling continued growth in the nation's third-largest medical market.